coronavirus briefing india & the coronavirus: modelling the … · distribution of covid-19 related...
TRANSCRIPT
-
Coronavirus Briefing
India & the Coronavirus:Modelling the Trajectory of Covid-19
Bhramar Mukherjee & the COV-IND-19 Study Group
Webinar, Friday, April 10, 2020, 5:30 p.m. IST
-
!"#$%&'%()*+,"(-#,(.,%)'#"/#)'%()*,0)$,%12-%&0'%()*,(.,0,345$06,-(&7$(8),(),'9#,:;54?,(@'A"#07,%),=)$%0
!"#$%&'$()*+,-./*012-3
!
!"#$"%&'($)*$+,$"-'.#)%/(.#0'1/+#12#(-%-#)*$&"%$)%)
!"#$%&'()*+,-./-*0&12.&3232
-
!"#$%&'()'&"*+%++&,
-%*"&'.%,/&,
0&&,%(.%'%1%*1%234$%5%*"
!63+37".%*&,8&&(
935%7.$%44%#$%,22%(
-&:,%8.6+&
;%,"/+$"4(
-
!"#$%&'()*+,-+.
!"#$%&'()'("*'+,-&('-*&.)$/*-&')+'0123456'7-,&,&'#-)8$/'("*'9)-:/;
!"#$#%&$"#'()&(*+,)-.'!/0.(1&2#11/+/&1#*3#*
!"#$%&'()*+*+)",#-.,$#/0,$%)102,3/%)04)52.6-6)!"15'
!!!"#$%&'(%)*"+,-
!17/,$')8889:/,72$,-#930; !",
-
!"#"$"%&"'()*(*+$(,*$-
"
5&($/7#!'%$*,"#5-'*6#89
5&($/7#!'%$*,!+'$,#:#
!"#$%&'()*#%*'+#,%+-.-%.)-$&"-)#$*/%-$+%*'001.0#$.%.'%)#")'+(*123#%&*1#$*#4%*'51$+678')9
https://medium.com/@covind_19/predictions-and-role-of-interventions-for-covid-19-outbreak-in-india-52903e2544e6https://medium.com/@covind_19/historic-lockdown-prediction-models-to-study-lockdown-effects-and-the-role-of-data-in-the-crisis-a0afeeec5a6http://covind19.org/
-
Outline
• Pre-lockdown forecasting
• Post-lockdown analysis
• Epidemiologic models: All are wrong, some are useful
• From numerical forecasting to strategic vision
5
-
12"%(,"(')3$)"4()20'(,*$-
$%&'()*+,!""#$%&&'''(#!)*+),-."/,)01"-,!230345(,3+&2-'$&/26/)1,37/61891,3*32)7/*.$1.#6)"-$1$")".$1:51$")"-&
0
10
20
30
40Ja
n.30
Feb.
02
Feb.
03
Feb.
16
Mar
.02
Mar
.04
Mar
.05
Mar
.06
Mar
.07
Mar
.08
Mar
.09
Mar
.10
Mar
.11
Mar
.12
Mar
.13
Mar
.14
Mar
.15
Mar
.16
Mar
.17
Mar
.18
Mar
.19
DeathRecoveredCase
Data source: Johns Hopkins University CSSECOVID-19 Confirmed New Cases/Recovered/Deaths by Day in India
Couple cases,no intervention
Sudden case increase,screening & travel bans start
Social distancing, closures,more travel bans
Heading towardslockdown
WHO declarespandemic
First case
© COV-IND-19 Study Group
https://www.pharmaceutical-technology.com/news/india-covid-19-coronavirus-updates-status-by-state/
-
Distribution of COVID-19 related risk factors
7
5
to support the sheer volume of cases. India has the most overstretched healthcare s stem here it is hard to pro ide care in times of normal patient volume. The number of hospital beds per 1000 people in India is only 0.7, compared to 6.5 in France, 11.5 in South Korea, 4.2 in China, 3.4 in Italy, 2.9 in the UK, 2.8 in the USA, and 1.5 in Iran [World Bank]. Need to emphasize that health care workers and front-line workers are among the most vulnerable.
Table 2. Proportion of population in specifically vulnerable subgroups at potentially high risk of COVID-19 severity risk in India
Metric Number†
(in millions) Year Source
Uninsured 1,104 2014 Prinja et al. 2019
Population over 65 92.5 2020 (est.) CIA World Factbook
Hypertension (men)* 175.7 2015/16 Gupta & Ram 2019
Hypertension (women)* 132.6 2015/16 Gupta & Ram 2019
People with cardiovascular disease* 78.7 2016 Prabhakaran et al. 2018
Population with COPD* 75.9 2016 Lancet 2018
Population with asthma* 45.5 2016 Lancet 2018
Develop cancer by age 75 (men)** 70.3 2018 NICPR
Develop cancer by age 75 (men)** 62.3 2018 NICPR
Population with diabetes (adult) 122.8 - IDF
Access to inpatient department facilities*** 731.4 2012 IMS Institute 2013
Access to outpatient department*** 1,104 2012 IMS Institute 2013
† based on 2020 est. of 1.38 billion from UN Department of Economic and Social Affairs * age-standardized; ** risk; *** defined as within 5 kilometer distance of home or work Abbrev.: COPD, chronic obstructive pulmonary disease; IDF, International Diabetes Federation; NICPR, National Institute of Cancer Prevention and Research
3. Do interventions like travel bans and social distancing help arrest the projected exponential growth of COVID-19?
Yes! We took a close look at what might be coming in the next few weeks and months, based on what we have seen in other countries and an improved epidemiological model that have been gainfully employed to
-
=$":/*&-4*,%(#*$"&3')
.
Forecast after Mar.16
Upper credible limit of predicted cases for India
* indicates any observed value after Mar.16
1
7
50
354
2507
17735
125490
887930
6282715
44454503
1
7
50
354
2507
17735
125490
887930
6282715
44454503
Feb.
01Fe
b.02
Feb.
03Fe
b.04
Feb.
05Fe
b.06
Feb.
07Fe
b.08
Feb.
09Fe
b.10
Feb.
11Fe
b.12
Feb.
13Fe
b.14
Feb.
15Fe
b.16
Feb.
17Fe
b.18
Feb.
19Fe
b.20
Feb.
21Fe
b.22
Feb.
23Fe
b.24
Feb.
25Fe
b.26
Feb.
27Fe
b.28
Feb.
29M
ar.0
1M
ar.0
2M
ar.0
3M
ar.0
4M
ar.0
5M
ar.0
6M
ar.0
7M
ar.0
8M
ar.0
9M
ar.1
0M
ar.1
1M
ar.1
2M
ar.1
3M
ar.1
4M
ar.1
5M
ar.1
6M
ar.1
7M
ar.1
8M
ar.1
9M
ar.2
0M
ar.2
1M
ar.2
2M
ar.2
3M
ar.2
4M
ar.2
5M
ar.2
6M
ar.2
7M
ar.2
8M
ar.2
9M
ar.3
0M
ar.3
1Ap
r.01
Apr.0
2Ap
r.03
Apr.0
4Ap
r.05
Apr.0
6Ap
r.07
Apr.0
8Ap
r.09
Apr.1
0Ap
r.11
Apr.1
2Ap
r.13
Apr.1
4Ap
r.15
Apr.1
6Ap
r.17
Apr.1
8Ap
r.19
Apr.2
0Ap
r.21
Apr.2
2Ap
r.23
Apr.2
4Ap
r.25
Apr.2
6Ap
r.27
Apr.2
8Ap
r.29
Apr.3
0M
ay.0
1M
ay.0
2M
ay.0
3M
ay.0
4M
ay.0
5M
ay.0
6M
ay.0
7M
ay.0
8M
ay.0
9M
ay.1
0M
ay.1
1M
ay.1
2M
ay.1
3M
ay.1
4M
ay.1
5
India US Italy
COVID!19 Cumulative Confirmed Cases by Day
© COV!IND!19 Study Group
-
>"403((&*?"$3@"
/
-
!"#$%&"'()*+,-.(/-$"%0-1(2%'3,%405(6-&'7()8
!0!"#$%"&'()("%*$)+,&-('.#(/"&0)$112),&23(#+,&(4&5$1)%"0&/().2),&0(&)+)%-&%)2%,&6407'(58
9$--$(",&-$1:0&'%"#-2,&$"&%&'(--2'0$*2$,;-%
-
Lockdown simply buys us time• To ramp up testing, disease surveillance, contact network tracing
• Prepare healthcare infrastructure
• Optimally deploy resources based on emerging hotspots
• Stop the virus: pause and then revive the economy
• Keeping the essential supply chain going and support the vulnerable
• Long-term strategy: instead of discrete short-term tactics 11
-
!1
45.*5*36789,*:9;79
&99.*,2*5,7?*,2>91@A*.5B@A*9@7539*
-
Questions that one can pose
• How many cases do we expect to see post lockdown?
• When can we expect to see a decline in fatalities?
• What does a successful lockdown look like?
• How should we return to normalcy from lockdown?
13
-
E+3/0)3)0?"(&*BC3$0'*%(: F+6"0G(720%3
!"
Lock
dow
n fro
m J
an.2
3Lo
ckdo
wn
from
Jan
.23
Lock
dow
n fro
m J
an.2
3Lo
ckdo
wn
from
Jan
.23
Lock
dow
n fro
m J
an.2
3Lo
ckdo
wn
from
Jan
.23
Lock
dow
n fro
m J
an.2
3
0
5000
10000
15000Ja
n.22
Jan.
24Ja
n.25
Jan.
26Ja
n.27
Jan.
28Ja
n.29
Jan.
30Ja
n.31
Feb.
01Fe
b.02
Feb.
03Fe
b.04
Feb.
05Fe
b.06
Feb.
07Fe
b.08
Feb.
09Fe
b.10
Feb.
11Fe
b.12
Feb.
13Fe
b.14
Feb.
15Fe
b.16
Feb.
17Fe
b.18
Feb.
19Fe
b.20
Feb.
21Fe
b.22
Feb.
23Fe
b.24
Feb.
25Fe
b.26
Feb.
27Fe
b.28
Feb.
29M
ar.0
1M
ar.0
2M
ar.0
3M
ar.0
4M
ar.0
5M
ar.0
6M
ar.0
7M
ar.0
8M
ar.0
9M
ar.1
0M
ar.1
1M
ar.1
2M
ar.1
3M
ar.1
4M
ar.1
5M
ar.1
6M
ar.1
7M
ar.1
8M
ar.1
9M
ar.2
0M
ar.2
1M
ar.2
2M
ar.2
3M
ar.2
4M
ar.2
5M
ar.2
6M
ar.2
7M
ar.2
8M
ar.2
9M
ar.3
0M
ar.3
1A
pr.0
1A
pr.0
2A
pr.0
3A
pr.0
4A
pr.0
5A
pr.0
6A
pr.0
7A
pr.0
8A
pr.0
9
DeathRecoveredCase
Data source: Johns Hopkins University CSSECOVID-19 Confirmed New Cases/Recovered/Deaths by Day in Hubei, China
Only lockdownin place
Lockdown, Centralized treatment& isolation strategies
Lockdown liftedin most of Hubei
© COV-IND-19 Study Group
-
E+3/0)3)0?"(&*BC3$0'*%(: H*+)2(I*$"3
!#
0
500
1000
1500Fe
b.01
Feb.
02Fe
b.04
Feb.
05Fe
b.06
Feb.
07Fe
b.09
Feb.
10Fe
b.11
Feb.
12Fe
b.15
Feb.
16Fe
b.17
Feb.
18Fe
b.20
Feb.
21Fe
b.22
Feb.
23Fe
b.24
Feb.
25Fe
b.26
Feb.
27Fe
b.28
Feb.
29M
ar.0
1M
ar.0
2M
ar.0
3M
ar.0
4M
ar.0
5M
ar.0
6M
ar.0
7M
ar.0
8M
ar.0
9M
ar.1
1M
ar.1
2M
ar.1
3M
ar.1
4M
ar.1
5M
ar.1
6M
ar.1
7M
ar.1
8M
ar.1
9M
ar.2
0M
ar.2
1M
ar.2
2M
ar.2
3M
ar.2
4M
ar.2
5M
ar.2
6M
ar.2
7M
ar.2
8M
ar.2
9M
ar.3
0M
ar.3
1A
pr.0
1A
pr.0
2A
pr.0
3A
pr.0
4A
pr.0
5A
pr.0
6A
pr.0
7A
pr.0
8A
pr.0
9
DeathRecoveredCase
Data source: Johns Hopkins University CSSECOVID-19 Confirmed New Cases/Recovered/Deaths by Day in South Korea
No lockdown; extensive testing, drive-through testing & contact tracing the whole time;voluntary social distancing and self-quarantine recommended
© COV-IND-19 Study Group
-
E+3/0)3)0?"(&*BC3$0'*%(: 9)3/D
!$
Lock
dow
n fro
m M
ar.0
9Lo
ckdo
wn
from
Mar
.09
Lock
dow
n fro
m M
ar.0
9Lo
ckdo
wn
from
Mar
.09
Lock
dow
n fro
m M
ar.0
9Lo
ckdo
wn
from
Mar
.09
Lock
dow
n fro
m M
ar.0
9
0
2500
5000
7500
Feb.
01Fe
b.07
Feb.
21Fe
b.22
Feb.
23Fe
b.24
Feb.
25Fe
b.26
Feb.
27Fe
b.28
Feb.
29M
ar.0
1M
ar.0
2M
ar.0
3M
ar.0
4M
ar.0
5M
ar.0
6M
ar.0
7M
ar.0
8M
ar.0
9M
ar.1
0M
ar.1
1M
ar.1
3M
ar.1
4M
ar.1
5M
ar.1
6M
ar.1
7M
ar.1
8M
ar.1
9M
ar.2
0M
ar.2
1M
ar.2
2M
ar.2
3M
ar.2
4M
ar.2
5M
ar.2
6M
ar.2
7M
ar.2
8M
ar.2
9M
ar.3
0M
ar.3
1A
pr.0
1A
pr.0
2A
pr.0
3A
pr.0
4A
pr.0
5A
pr.0
6A
pr.0
7A
pr.0
8A
pr.0
9
DeathRecoveredCase
Data source: Johns Hopkins University CSSECOVID-19 Confirmed New Cases/Recovered/Deaths by Day in Italy
Travel bans, state of emergency,quarantine zones
National quarantine Complete lockdown
© COV-IND-19 Study Group
-
E+3/0)3)0?"(&*BC3$0'*%(: 9%403
!-
Lock
dow
n fro
m M
ar.2
5Lo
ckdo
wn
from
Mar
.25
Lock
dow
n fro
m M
ar.2
5Lo
ckdo
wn
from
Mar
.25
Lock
dow
n fro
m M
ar.2
5Lo
ckdo
wn
from
Mar
.25
0
500
1000
Feb.
01Fe
b.02
Feb.
03Fe
b.16
Mar
.02
Mar
.04
Mar
.05
Mar
.06
Mar
.07
Mar
.08
Mar
.09
Mar
.10
Mar
.11
Mar
.12
Mar
.13
Mar
.14
Mar
.15
Mar
.16
Mar
.17
Mar
.18
Mar
.19
Mar
.20
Mar
.21
Mar
.22
Mar
.23
Mar
.24
Mar
.25
Mar
.26
Mar
.27
Mar
.28
Mar
.29
Mar
.30
Mar
.31
Apr
.01
Apr
.02
Apr
.03
Apr
.04
Apr
.05
Apr
.06
Apr
.07
Apr
.08
Apr
.09
DeathRecoveredCase
Data source: Johns Hopkins University CSSECOVID-19 Confirmed New Cases/Recovered/Deaths by Day in India
Couple cases,no intervention
Sudden case increase,screening & travel bans start
Social distancing,closures
Heading towardslockdown
Lockdown
© COV-IND-19 Study Group
-
Forecasting Models (India specific)
• ICMR• Cambridge• Armed Forces• Sourish Das (CMI)• Ohio State University
18
https://www.ncbi.nlm.nih.gov/pubmed/32202261https://arxiv.org/abs/2003.12055https://www.sciencedirect.com/science/article/pii/S0377123720300605https://arxiv.org/pdf/2004.03147.pdfhttps://www.medrxiv.org/content/10.1101/2020.04.02.20051466v1
-
H9!(B*4"/M(#+%43B"%)3/'
4 !"#$%"$#&'($,8I&/(-=7+&*=&*+&7+(&7I-((&J=>,>(=KL
!/
;/)*&+%$-,+=A*==*7+=&C=*+?&87C+>&:,>,L4 -./++&01&'(M-C(&/-7/7->*7+=&C+9+7;+N
@ @ @
-
J3&0%@()2"(&23//"%@"M("N)"%4"4(H9!
10
4 23&/'(O+>-7:C8(&,&0,>(+>&P,-97E&/-78(==L
A-"0#&%#-,4#89894#&;=> +-*B-0"#>#C>!D#
-
eSIR model: hierarchical formulation and solution
!"!"
!#= −𝛽𝜃#$𝜃#%,
!"!#
!#= 𝛽𝜃#$𝜃#% − 𝛾𝜃#%,
!"!$
!#= 𝛾𝜃#%.
𝑌#%|𝜽𝒕, 𝝉 ∼ 𝐵𝑒𝑡𝑎(𝜆%𝜃#% , 𝜆% 1 − 𝜃#% ),𝑌#'|𝜽𝒕, 𝝉 ∼ 𝐵𝑒𝑡𝑎(𝜆'𝜃#' , 𝜆' 1 − 𝜃#' ).
𝜽𝒕|𝜽𝒕(𝟏, 𝝉 ∼ 𝐷𝑖𝑟𝑖𝑐ℎ𝑙𝑒𝑡(𝜅𝑓(𝜽𝒕(𝟏, 𝛽, 𝛾)).
• Given the values at the previous step, the system can then be solvedfor 𝑓 using approximations.
21
Compartmental Specification
Building autocorrelation
Reff= 𝛽/𝛾
-
Bayesian specification and Markov chain Monte Carlo (MCMC) sampling
• Priors: 𝜽𝟎~𝐷𝑖𝑟𝑖𝑐ℎ𝑙𝑒𝑡(1 − 𝑌"# − 𝑌"$, 𝑌"#, 𝑌"$), 𝜃%& = 1 − 𝜃%# − 𝜃%$.• Can set priors/initial choices for 𝑅%, 𝛾 in data dependent way.• Begin with large variances that can be tuned with more data
coming in.𝜅, 𝜆#, 𝜆$~𝐺𝑎𝑚𝑚𝑎 2, 0.0001 𝑖𝑖𝑑.
• Learn the SIR dynamics from the observed data first, and then use MCMC to iterate between latent and observed proportions.
22
-
>*4"/0%@(0%)"$?"%)0*%'
12
!"!"
!#! "#
-
Forecasting scenarios and assumptions
• No intervention• Social distancing and travel ban (without lockdown)
Post-lockdown• 21-day lockdown with gradual resumption of activities at
different levels:• Moderate • Cautious • Normal (pre-intervention)
24
-
R0 under two hypothetical scenarios
25
Lockdown begins Lockdown ends
0.0
0.5
1.0
1.5
2.0
Mar 01 Apr 01 May 01Date
Impl
ied
R0
Scenario
Cautious return
Moderate return
Normal (pre−intervention)
Soc. Dist. + Travel Ban
quick adherence (1−week delay)
R0 over time by scenario
© COV−IND−19 Study Group
Lockdown begins Lockdown ends
0.0
0.5
1.0
1.5
2.0
Mar 01 Apr 01 May 01Date
Impl
ied
R0
Scenario
Cautious return
Moderate return
Normal (pre−intervention)
Soc. Dist. + Travel Ban
slow adherence (2−week delay)
R0 over time by scenario
© COV−IND−19 Study Group
quick
slow
-
H2*$)()"$B(O P+0&-(342"$"%&"
1$
Observed
No intervention
Social distancing
Lockdown with moderate release
1
10
100
1,000
10,000
100,000
1,000,000
1
10
100
1,000
10,000
100,000
1,000,000
Mar 0
1
Mar 1
5Ap
r 01
Apr 1
5
May 0
1
Date
Cum
ulat
ive n
umbe
r of c
ases
as of 07 April 2020COVID!19 Cumulative Cases by Day for India
© COV!IND!19 Study Group
=5,"'(GH(&+4"7%4& I55&,('"7"4
3&,456*(7*564&5 !"#$%&' ($(''$&&(%&)489,:4;685)45< &)$*(! ())$""+=&)>:&?5,@A&:*(86*B '$+%+ #($(&"
-
H2*$)()"$B(O '/*,(342"$"%&"
1-
Observed
No intervention
Social distancing
Lockdown with moderate release
1
10
100
1,000
10,000
100,000
1,000,000
1
10
100
1,000
10,000
100,000
1,000,000
Mar 0
1
Mar 1
5Ap
r 01
Apr 1
5
May 0
1
Date
Cum
ulat
ive n
umbe
r of c
ases
as of 07 April 2020COVID!19 Cumulative Cases by Day for India
© COV!IND!19 Study Group
=5,"'(GH(&+4"7%4& I55&,('"7"4
3&,456*(7*564&5 !"#$%&' ($(''$&&(
%&)489,:4;685)45< "&$#(% !!($*!(
=&)>:&?5,@A&:*(86*B ++,-.- %&$(%"
-
Long term – quick adherence
28
Difference between social distancing andcautious return on May 15: 343,145 cases
Difference between social distancing andcautious return on June 15: 2,376,468 cases
Difference between social distancing andcautious return on July 15: 4,589,917 cases
0
200
400
May 0
1
Jun 0
1Ju
l 01
Aug 0
1
Date
Num
ber o
f inf
ecte
d ca
ses
per 1
00,0
00 p
eopl
e in
Indi
a ScenarioCautious return
Moderate return
Normal (pre−intervention)
Soc. Dist. + Travel Ban
as of 07 April 2020Predicted number of COVID−19 cases in India under hypothetical scenarios
© COV−IND−19 Study Group
Cautious 5/15: 16,520 Cautious 6/15: 251,636 Cautious 7/15: 927,407
-
Long term – quick adherence
29
Difference between social distancing andcautious return on May 15: 36,062 cases
Difference between social distancing andcautious return on June 15: 79,492 cases
Difference between social distancing andcautious return on July 15: 65,018 cases
0
3
6
9
May 0
1
Jun 0
1Ju
l 01
Aug 0
1
Date
Num
ber o
f new
cas
es p
er 1
00,0
00 p
eopl
e in
Indi
a
ScenarioCautious return
Moderate return
Normal (pre−intervention)
Soc. Dist. + Travel Ban
as of 07 April, 2020Predicted number of new COVID−19 cases in India under hypothetical scenarios
© COV−IND−19 Study Group
Cautious 5/15: 1,053 Cautious 6/15: 16,298 Cautious 7/15: 25,503
-
Long term – slow adherence
30
Difference between social distancing andcautious return on May 15: 438,789 cases
Difference between social distancing andcautious return on June 15: 3,369,834 cases
Difference between social distancing andcautious return on July 15: 6,403,186 cases
0
200
400
600
May 0
1
Jun 0
1Ju
l 01
Aug 0
1
Date
Num
ber o
f inf
ecte
d ca
ses
per 1
00,0
00 p
eopl
e in
Indi
a ScenarioCautious return
Moderate return
Normal (pre−intervention)
Soc. Dist. + Travel Ban
as of 07 April 2020Predicted number of COVID−19 cases in India under hypothetical scenarios
© COV−IND−19 Study Group
Cautious 5/15: 17,477 Cautious 6/15: 188,249 Cautious 7/15: 812,795
-
Long term – slow adherence
31
Difference between social distancing andcautious return on May 15: 49,188 cases
Difference between social distancing andcautious return on June 15: 115,025 cases
Difference between social distancing andcautious return on July 15: 83,560 cases
0
3
6
9
May 0
1
Jun 0
1Ju
l 01
Aug 0
1
Date
Num
ber o
f new
cas
es p
er 1
00,0
00 p
eopl
e in
Indi
a
ScenarioCautious return
Moderate return
Normal (pre−intervention)
Soc. Dist. + Travel Ban
as of 07 April, 2020Predicted number of new COVID−19 cases in India under hypothetical scenarios
© COV−IND−19 Study Group
Cautious 5/15: 699 Cautious 6/15: 12,887 Cautious 7/15: 26,012
-
7.89Q5;
-
Takeaway messages• High uncertainty in predicted numbers (note large upper credible limit)
• Variation in predictions increases as we go further in time
• Outputs change everyday and data trumps models
• Relative comparison of interventions are still meaningful
• Need some form of suppression in place post-lockdown (cautious return)
• A rigorous lens to quantify the pulse and movements of an epidemic but an incomplete description of the costs of interventions and what society is undergoing as a whole
33
-
9'(9%403()$+/D(40##"$"%)U
2"
3 day
s
6 days
14 days
100
1,000
10,000
100,000
1,000,000
100
1,000
10,000
100,000
1,000,000
0 20 40 60Days since cases reached 100
Cum
ulat
ive n
umbe
r of c
ases
CountryChina
France
Germany
India
Iran
Italy
South Korea
US
-
Hypotheses• Limited Testing, Testing Strategy and Criteria
• Reporting of deaths
• Temperature
• BCG vaccinations, use of antimalarials, genetics, immunity
• Younger population
35
\
https://www.medrxiv.org/content/10.1101/2020.04.01.20049478v1
-
2$2$%&'()*+,!""#$%&&;/7-"!/*"5-/4!"(,3+&;-)".*-$&,3*32)7/*.$1,)$-1,3.2"$1)*-1+-)2/240-$$&
https://fivethirtyeight.com/features/coronavirus-case-counts-are-meaningless/
-
37
30 March 2020 Imperial College COVID-19 Response Team
DOI: https://doi.org/10.25561/77731 Page 1 of 35
Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries Seth Flaxman*, Swapnil Mishra*, Axel Gandy*, H Juliette T Unwin, Helen Coupland, Thomas A Mellan, Harrison Zhu, Tresnia Berah, Jeffrey W Eaton, Pablo N P Guzman, Nora Schmit, Lucia Cilloni, Kylie E C Ainslie, Marc Baguelin, Isobel Blake, Adhiratha Boonyasiri, Olivia Boyd, Lorenzo Cattarino, Constanze Ciavarella, Laura Cooper, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Bimandra Djaafara, Ilaria Dorigatti, Sabine van Elsland, Rich FitzJohn, Han Fu, Katy Gaythorpe, Lily Geidelberg, Nicholas Grassly, Will Green, Timothy Hallett, Arran Hamlet, Wes Hinsley, Ben Jeffrey, David Jorgensen, Edward Knock, Daniel Laydon, Gemma Nedjati-Gilani, Pierre Nouvellet, Kris Parag, Igor Siveroni, Hayley Thompson, Robert Verity, Erik Volz, Caroline Walters, Haowei Wang, Yuanrong Wang, Oliver Watson, Peter Winskill, Xiaoyue Xi, Charles Whittaker, Patrick GT Walker, Azra Ghani, Christl A. Donnelly, Steven Riley, Lucy C Okell, Michaela A C Vollmer, Neil M. Ferguson1 and Samir Bhatt*1
Department of Infectious Disease Epidemiology, Imperial College London Department of Mathematics, Imperial College London WHO Collaborating Centre for Infectious Disease Modelling MRC Centre for Global Infectious Disease Analysis Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London Department of Statistics, University of Oxford *Contributed equally 1Correspondence: [email protected], [email protected]
Summary Following the emergence of a novel coronavirus (SARS-CoV-2) and its spread outside of China, Europe is now experiencing large epidemics. In response, many European countries have implemented unprecedented non-pharmaceutical interventions including case isolation, the closure of schools and universities, banning of mass gatherings and/or public events, and most recently, widescale social distancing including local and national lockdowns.
In this report, we use a semi-mechanistic Bayesian hierarchical model to attempt to infer the impact of these interventions across 11 European countries. Our methods assume that changes in the reproductive number a measure of transmission - are an immediate response to these interventions being implemented rather than broader gradual changes in behaviour. Our model estimates these changes by calculating backwards from the deaths observed over time to estimate transmission that occurred several weeks prior, allowing for the time lag between infection and death.
One of the key assumptions of the model is that each intervention has the same effect on the reproduction number across countries and over time. This allows us to leverage a greater amount of data across Europe to estimate these effects. It also means that our results are driven strongly by the data from countries with more advanced epidemics, and earlier interventions, such as Italy and Spain. We find that the slowing growth in daily reported deaths in Italy is consistent with a significant impact of interventions implemented several weeks earlier. In Italy, we estimate that the effective reproduction number, Rt, dropped to close to 1 around the time of lockdown (11th March), although with a high level of uncertainty.
Overall, we estimate that countries have managed to reduce their reproduction number. Our estimates have wide credible intervals and contain 1 for countries that have implemented all interventions considered in our analysis. This means that the reproduction number may be above or below this value. With current interventions remaining in place to at least the end of March, we estimate that interventions across all 11 countries will have averted 59,000 deaths up to 31 March [95% credible interval 21,000-120,000]. Many more deaths will be averted through ensuring that interventions remain in place until transmission drops to low levels. We estimate that, across all 11 countries between 7 and 43 million individuals have been infected with SARS-CoV-2 up to 28th March, representing between 1.88% and 11.43% of the population. The proportion of the population infected
Source: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Europe-estimates-and-NPI-impact-30-03-2020.pdf/
https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Europe-estimates-and-NPI-impact-30-03-2020.pdf/
-
,-./012 345.61-71./6.6189:14-.1;/1.>1?-@4.=5/6A2 &/0)123B@8@>9.5C/1.-.9>1./6.61D/=185>>5-41E1B@8@>9.5C/1?-475=8/F1?96/61D/=185>>5-42 GFH@6./F1IJ6K@9=/FL*A)%# %&'()*+,!""#$%&&3.*'3*06/26)")(3*4&,37/61"-$"/24F,,37/689/26/)(3*4
https://ourworldindata.org/covid-testinghttp://covid19india.org/
-
0
20000
40000
60000
80000
100000
120000
140000
3/6/2020
3/7/2020
3/8/2020
3/9/2020
3/10/2020
3/11/2020
3/12/2020
3/13/2020
3/14/2020
3/15/2020
3/16/2020
3/17/2020
3/18/2020
3/19/2020
3/20/2020
3/21/2020
3/22/2020
3/23/2020
3/24/2020
3/25/2020
3/26/2020
3/27/2020
3/28/2020
3/29/2020
3/30/2020
3/31/2020
4/1/2020
4/2/2020
US
PositiveIncrease NegativeIncrease
Average positive rate 0.151
Highest positive rate 0.315
US daily tests versus daily incidence
Source: https://ourworldindata.org/covid-testing; covid19india.org
https://ourworldindata.org/covid-testinghttp://covid19india.org/
-
0
2000
4000
6000
8000
10000
12000
1/31/2020
2/2/2020
2/4/2020
2/6/2020
2/8/2020
2/10/2020
2/12/2020
2/14/2020
2/16/2020
2/18/2020
2/20/2020
2/22/2020
2/24/2020
2/26/2020
2/28/2020
3/1/2020
3/3/2020
3/5/2020
3/7/2020
3/9/2020
3/11/2020
3/13/2020
3/15/2020
3/17/2020
3/19/2020
3/21/2020
3/23/2020
3/25/2020
3/27/2020
3/29/2020
3/31/2020
4/2/2020
UK
PositiveIncrease NegativeIncrease
UK daily tests versus daily incidence
Source: https://ourworldindata.org/covid-testing; covid19india.org
Average positive rate 0.078
Highest positive rate 0.423
https://ourworldindata.org/covid-testinghttp://covid19india.org/
-
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
1/22/2020
1/24/2020
1/26/2020
1/28/2020
1/30/2020
2/1/2020
2/3/2020
2/5/2020
2/7/2020
2/9/2020
2/11/2020
2/13/2020
2/15/2020
2/17/2020
2/19/2020
2/21/2020
2/23/2020
2/25/2020
2/27/2020
2/29/2020
3/2/2020
3/4/2020
3/6/2020
3/8/2020
3/10/2020
3/12/2020
3/14/2020
3/16/2020
3/18/2020
3/20/2020
3/22/2020
3/24/2020
3/26/2020
3/28/2020
3/30/2020
4/1/2020
4/3/2020
South Korea
PositiveIncrease NegativeIncrease
South Korea daily tests versus daily incidence
Source: https://ourworldindata.org/covid-testing; covid19india.org
Average positive rate 0.021
Highest positive rate 0.111
https://ourworldindata.org/covid-testinghttp://covid19india.org/
-
0
200
400
600
800
1000
1200
1400
1600
1800
2000
2/27/2020
2/28/2020
2/29/2020
3/1/2020
3/2/2020
3/3/2020
3/4/2020
3/5/2020
3/6/2020
3/7/2020
3/8/2020
3/9/2020
3/10/2020
3/11/2020
3/12/2020
3/13/2020
3/14/2020
3/15/2020
3/16/2020
3/17/2020
3/18/2020
3/19/2020
3/20/2020
3/21/2020
3/22/2020
3/23/2020
3/24/2020
3/25/2020
3/26/2020
3/27/2020
3/28/2020
3/29/2020
3/30/2020
3/31/2020
4/1/2020
4/2/2020
Iceland
PositiveIncrease NegativeIncrease
Iceland daily tests versus daily incidence
Source: https://ourworldindata.org/covid-testing; covid19india.org
Average positive rate 0.079
Highest positive rate 0.350
https://ourworldindata.org/covid-testinghttp://covid19india.org/
-
India daily tests versus daily incidence
0
2000
4000
6000
8000
10000
12000
14000
16000
3/19/2020
3/20/2020
3/21/2020
3/22/2020
3/23/2020
3/24/2020
3/25/2020
3/26-3/27/2020
3/28-4/1/2020
4/2/2020
4/3/2020
4/4/2020
4/5/2020
4/6/2020
4/7/2020
4/8/2020
Source: https://ourworldindata.org/covid-testing; covid19india.org
Average positive rate 0.04
Highest positive rate 0.07
https://ourworldindata.org/covid-testinghttp://covid19india.org/
-
Summer Boon?
44
Month Correlation 95% Confidence Interval
Countries with non-zero incidence
January -0.185 [-0.55, 0.24] 24
February -0.110 [-0.362, 0.157] 56
March -0.173 [-0.314, -0.026] 175
-
"#
K(+)'2L&!""#$%&&!'()"!*'("!'+,-$&./01'23"4#56()
=#"0>(,-$-($%('7-#:($7:(,"#:-#:($&-'3#
K(+)'2L&!""#$%&&***,7007)',60/&608519:&/0;5)5"4&
https://healthweather.us/%3Fmode=Atypicalhttps://www.google.com/covid19/mobility/
-
Summary (as data scientists)
• Public health and economics are at a competing interest
• Use of data (mobile network, hospital admissions, temperature maps) to chase the epidemic and nip it in the bud
• Nimble policymaking (pause, push and drive) in a data adaptive way
• Use data to estimate need, deploy resources, how many beds, PPE, ICU beds, ventilators are needed and where?
46
-
"-"-
-
Austrian Poet Rainer Maria Rilke said, “Let everything happen to you. The beauty and the terror. Just keep going. No feeling is final.”
-
T23%-(X*+(3%4(=/"3'"(H)3D(H3#"G(H)3D(F*B"S
"/
-
Back up slides: Length of lockdown
50
-
R0 under lockdown length scenarios
51
Lockdown begins Lockdown ends
0.0
0.5
1.0
1.5
2.0
Mar 01 Apr 01 May 01 Jun 01 Jul 01Date
Impl
ied
R0
Scenario
21−day lockdown
28−day lockdown
42−day lockdown
56−day lockdown
as of 07 April, 2020
R0 over time by scenario
© COV−IND−19 Study Group
Lockdown begins Lockdown ends
0.0
0.5
1.0
1.5
2.0
Mar 01 Apr 01 May 01 Jun 01 Jul 01Date
Impl
ied
R0
Scenario
21−day lockdown
28−day lockdown
42−day lockdown
56−day lockdown
as of 07 April, 2020
R0 over time by scenario
© COV−IND−19 Study Group
-
Lockdown lengths – quick adherence
52
0
50
100
150
200
250
May 0
1
Jun 0
1Ju
l 01
Aug 0
1
Date
Num
ber o
f inf
ecte
d ca
ses
per 1
00,0
00 p
eopl
e in
Indi
a Scenario21−day lockdown
28−day lockdown
42−day lockdown
56−day lockdown
as of 07 April, 2020Predicted number of COVID−19 infections under varying lockdown lengths
© COV−IND−19 Study Group
-
Lockdown lengths – quick adherence
53
0
1
2
3
4
May 0
1
Jun 0
1Ju
l 01
Aug 0
1
Date
Num
ber o
f inf
ecte
d ca
ses
per 1
00,0
00 p
eopl
e in
Indi
a Scenario21−day lockdown
28−day lockdown
42−day lockdown
56−day lockdown
as of 07 April, 2020Predicted number of daily COVID−19 infections under varying lockdown lengths
© COV−IND−19 Study Group
-
Lockdown lengths – slow adherence
54
0
50
100
150
200
250
May 0
1
Jun 0
1Ju
l 01
Aug 0
1
Date
Num
ber o
f inf
ecte
d ca
ses
per 1
00,0
00 p
eopl
e in
Indi
a Scenario21−day lockdown
28−day lockdown
42−day lockdown
56−day lockdown
as of 07 April, 2020Predicted number of COVID−19 infections under varying lockdown lengths
© COV−IND−19 Study Group
-
Lockdown lengths – slow adherence
55
0
1
2
3
4
May 0
1
Jun 0
1Ju
l 01
Aug 0
1
Date
Num
ber o
f inf
ecte
d ca
ses
per 1
00,0
00 p
eopl
e in
Indi
a Scenario21−day lockdown
28−day lockdown
42−day lockdown
56−day lockdown
as of 07 April, 2020Predicted number of daily COVID−19 infections under varying lockdown lengths
© COV−IND−19 Study Group
-
A Conceptual Model
56
S E R
A = AUT + ATFN
I = ITTP + ITFP
Unreported, untested cases plus false negative tests
Tested and reported
Managed at home Hospitalized
ICU: severe disease
DeathNon random samplingWho are we testing?
Title slide WebinarNCAER_COVIND19_Slides